Treatment with antibodies to leucocyte function-associated antigen-1 prolongs the survival of xenotransplanted islets of Langerhans

Transplant Proc. 1994 Jun;26(3):1360-1.

Authors

L Bühler¹, S Deng, G Grau, G Mentha, A Rohner, P Morel

Affiliation

¹ Department of Surgery, University Hospital Geneva, Switzerland.

PMID: 8029940

No abstract available

Publication types

Comparative Study
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Antibodies, Monoclonal / therapeutic use*
Diabetes Mellitus, Experimental / surgery
Graft Rejection / immunology
Graft Rejection / pathology
Graft Rejection / prevention & control
Graft Survival / drug effects
Graft Survival / immunology*
Immunoglobulin G / therapeutic use
Islets of Langerhans Transplantation / immunology*
Islets of Langerhans Transplantation / pathology
Lymphocyte Function-Associated Antigen-1 / immunology*
Mice
Mice, Inbred C57BL
Rats
Rats, Sprague-Dawley
Transplantation, Heterologous / immunology*
Transplantation, Heterologous / pathology

Substances

Antibodies, Monoclonal
Immunoglobulin G
Lymphocyte Function-Associated Antigen-1